Level of Anxiety Among Nurses Working in Psychiatric Settings (Anxiété-IDE)

February 10, 2026 updated by: Université de Reims Champagne-Ardenne

Anxiety is common among healthcare professionals, particularly nurses, who are faced with major responsibilities and stressful situations. In psychiatric settings, this stress is exacerbated by exposure to patients with serious mental disorders (schizophrenia, bipolarity, personality disorders), who are often unpredictable and sometimes violent. Nurses in this sector face an increased risk of violence, work overload and an emotionally taxing environment, which can lead to chronic anxiety, burn-out and even mental health problems.

These professionals also have to manage the ambiguity of their role, between caring for and containing patients, in a context where training in crisis management is often inadequate.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary objective is to describe the level of anxiety in nurses practising in psychiatric settings.

The secondary objectives are :

  • describe the impact of anxiety levels on professional and personal life.
  • to identify the factors associated with anxiety levels in nurses working in psychiatry.

Study Type

Observational

Enrollment (Actual)

543

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51100
        • Ufr Medecine Urca
    • Champagne-Ardenne
      • Reims, Champagne-Ardenne, France, 51100
        • Gestonnairedu CURRS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

State-registered nurse

Description

Inclusion Criteria:

  • State-registered nurse,
  • Practising for more than one year in a psychiatric environment, whether in a full or partial hospitalisation unit, or in a medical-psychological centre
  • Whatever positions they previously held
  • Agreeing to take part in the study.

Exclusion Criteria:

  • nursing students
  • Practising for less than a year in a psychiatric setting
  • Protected by law (guardianship, curatorship, safeguard of justice)
  • Refusing to take part in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
STAI Scale (State Trait Anxiety Inventory, Y-A form)
Time Frame: Day 0
the level of anxiety assessed by Spielberger's State Anxiety Inventory (STAI - Trait Anxiety Inventory Form Y-A scale). (12)
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2025

Primary Completion (Actual)

May 13, 2025

Study Completion (Actual)

June 15, 2025

Study Registration Dates

First Submitted

February 10, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024_RIPH_25_anxiete-IDE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe